Medizinische Hochschule Hannover (MHH) / Hannover Medical School

University / College


Location: Hannover, Germany (DE) DE

ISNI: 0000000095299877

ROR: https://ror.org/00f2yqf98

Show on Map:

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

S2k Guideline: Diagnosis in case of suspected Betalactam Antibiotic Hypersensitivity (2019) Wurpts G, Aberer W, Dickel H, Brehler R, Jakob T, Kreft B, Mahler V, et al. Journal article ARIA guideline 2019: treatment of allergic rhinitis in the German health system (2019) Klimek L, Bachert C, Pfaar O, Becker S, Bieber T, Brehler R, Buhl R, et al. Journal article Isolated nocturnal and isolated daytime hypertension associate with altered cardiovascular morphology and function in children with chronic kidney disease: findings from the Cardiovascular Comorbidity in Children with Chronic Kidney Disease study (2019) Düzova A, Karabay Bayazit A, Canpolat N, Niemirska A, Kaplan Bulut I, Azukaitis K, Karagoz T, et al. Journal article Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities (2019) Reinhardt A, Stichel D, Schrimpf D, Koelsche C, Wefers AK, Ebrahimi A, Sievers P, et al. Journal article Seizure rates under treatment with antipsychotic drugs: Data from the AMSP project (2019) Druschky K, Bleich S, Grohmann R, Engel RR, Neyazi A, Stuebner S, Toto S Journal article Secondary prevention measures in anaphylaxis patients: Data from the anaphylaxis registry (2019) Kraft M, Knop MP, Renaudin JM, Scherer Hofmeier K, Pfoehler C, Bilo MB, Lang R, et al. Journal article Constitutive TNF-α signaling in neonates is essential for the development of tissue-resident leukocyte profiles at barrier sites (2019) Bickes MS, Pirr S, Heinemann AS, Fehlhaber B, Halle S, Voellger L, Willers M, et al. Journal article Early Symptom Improvement With Risankizumab Treatment in Patients With Moderately to Severely Active Crohn's Disease: Analysis From a Phase 2 Study (2019) Feagan BG, Sandborn WJ, D'Haens GR, Panes J, Kaser A, Ferrante M, Louis E, et al. Conference contribution A phase I dose-escalation and expansion trial of intratumorally administered CV8102, alone and in combination with anti-PD-1 in patients with advanced solid tumours (2019) Krauss J, Eigentler T, Schreiber J, Weishaupt C, Terheyden P, Heinzerling L, Mohr P, et al. Conference contribution MOLECULAR DIAGNOSIS OF KIDNEY TRANSPLANT FAILURE BY THE URINE (2019) Knaup K, Wiesener A, Buettner-Herold M, Dieterle A, Morath C, Vondran FWR, Wald A, et al. Conference contribution
‹ 1 ... 78 79 80 81 82 ... 147 ›